ClementineAI, a Maastricht-based startup, has raised €1.7 million ($2 million) in Seed funding to scale its AI-powered hearing care platform. The round was led by Healthy.Capital, an Amsterdam-based early-stage HealthTech investor.
TL;DR
- ClementineAI raises €1.7M Seed funding to expand its AI hearing care platform.
- The platform's AI agent, Matthew, engages with prospective patients 24/7, improving clinic efficiency and patient outcomes.
- Funding will deepen AI capabilities and expand partnerships with hearing clinics and healthcare organizations.
What happened
ClementineAI, founded in 2024 by Vince van de Weijer, has developed an AI hearing activation platform designed for the hearing-care industry. The platform features Matthew, an AI hearing care agent that engages with prospective patients, answering questions, educating users, and guiding them toward appropriate care.
The €1.7 million ($2 million) Seed funding round was led by Healthy.Capital, an Amsterdam-based early-stage HealthTech investor. The funding will be used to deepen the company's AI capabilities and expand its partnerships with hearing clinics, optical retailers, and other healthcare organizations.
Why it matters
For hearing clinics, ClementineAI's platform can eliminate administrative work for staff and translate calls into bookings. This can help clinics struggling to answer every patient inquiry, improving overall efficiency.
For patients, the platform offers streamlined communication and improved hearing outcomes. The AI agent provides a judgement-free, always-available way to begin engaging with hearing care before patients are ready to walk into a clinic.
The funding and partnership with Zoolstra, a marketing agency serving hearing clinics in the US and Canada, indicate ClementineAI's potential for global scalability. The company aims to address the significant gap in hearing care, with nearly 80% of those affected by hearing loss never seeking treatment.
Key facts
- ClementineAI raised €1.7 million ($2 million) in Seed funding.
- The round was led by Healthy.Capital, an Amsterdam-based early-stage HealthTech investor.
- The company was founded in 2024 by Vince van de Weijer, who serves as founder and CEO.
- ClementineAI's platform features Matthew, an AI hearing care agent that engages with prospective patients 24/7.
- The platform aims to improve clinic efficiency and patient outcomes by streamlining communication and providing always-available care.
- The funding will be used to deepen AI capabilities and expand partnerships with hearing clinics and healthcare organizations.
- ClementineAI has partnered with Zoolstra, a marketing agency serving hearing clinics in the US and Canada.
- Hearing loss affects an estimated 1.5 billion people worldwide, with nearly 80% never seeking treatment.
Context
ClementineAI's platform addresses a significant gap in hearing care, with a large portion of those affected by hearing loss never seeking treatment. By pairing AI with behavioral science, the platform aims to provide a judgement-free, always-available way to begin engaging with hearing care.
The company's recent funding and partnership with Zoolstra indicate its potential for global scalability. As the hearing-care industry continues to evolve, AI-powered platforms like ClementineAI's could play a significant role in improving patient engagement and clinic efficiency.
The funding round comes as the hearing-care industry faces increasing pressure to improve patient outcomes and streamline operations. AI-powered platforms like ClementineAI's could help clinics meet these challenges by providing always-available care and improving overall efficiency.
